97
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study

ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 909-917 | Received 14 Dec 2023, Accepted 23 Feb 2024, Published online: 08 Mar 2024

References

  • Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-1980: incidence, treatment, and survival. Br J Ophthalmol. 1988;72(8):576–583. doi:10.1136/bjo.72.8.576
  • Moll AC, Kuik DJ, Bouter LM, et al. Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995. Br J Ophthalmol. 1997;81(7):559–562. doi:10.1136/bjo.81.7.559
  • Saw SM, Tan N, Lee SB, Au Eong KG, Chia KS. Incidence and survival characteristics of retinoblastoma in Singapore from 1968-1995. J Pediatr Ophthalmol Strabismus. 2000;37(2):87–93. doi:10.3928/0191-3913-20000301-07
  • Seregard S, Lundell G, Svedberg H, Kivela T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology. 2004;111(6):1228–1232. doi:10.1016/j.ophtha.2003.10.023
  • Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):21–23. doi:10.1136/bjo.2008.138750
  • Nyamori JM, Kimani K, Njuguna MW, Dimaras H. The incidence and distribution of retinoblastoma in Kenya. Br J Ophthalmol. 2012;96(1):141–143. doi:10.1136/bjophthalmol-2011-300739
  • Dean M, Bendfeldt G, Lou H, et al. Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala. Cancer Lett. 2014;351(1):59–63. doi:10.1016/j.canlet.2014.04.023
  • Moreno F, Sinaki B, Fandino A, Dussel V, Orellana L, Chantada G. A population-based study of retinoblastoma incidence and survival in Argentine children. Pediatr Blood Cancer. 2014;61(9):1610–1615. doi:10.1002/pbc.25048
  • Park SJ, Woo SJ, Park KH. Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993-2010). Invest Ophthalmol Vis Sci. 2014;55(5):2816–2821. doi:10.1167/iovs.14-14078
  • Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: a 40-Year Incidence and Survival Analysis. J Pediatr Ophthalmol Strabismus. 2018;55(3):182–188. doi:10.3928/01913913-20171116-03
  • El Hage S, Wakim E, Daou L, El Masri J, Salameh P. Epidemiology and Incidence of Retinoblastoma in the Middle East: a Nationwide Study in Lebanon. Cureus. 2021;13(10).
  • Nowak MS, Romanowska-Dixon B, Grabska-Liberek I, Zurek M. Incidence and Characteristics of Retinoblastoma in Poland: the First Nationwide Study 2010-2017. Int J Environ Res Public Health. 2021;18(12):6539.
  • Nummi K, Kivela TT. Retinoblastoma in Finland, 1964-2014: incidence and survival. Br J Ophthalmol. 2021;105(1):63–69. doi:10.1136/bjophthalmol-2019-315744
  • Stacey AW, Bowman R, Foster A, et al. Incidence of Retinoblastoma Has Increased: results from 40 European Countries. Ophthalmology. 2021;128(9):1369–1371. doi:10.1016/j.ophtha.2021.01.024
  • Yousef YA, Mohammad M, Al-Nawaiseh I, et al. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic Genet. 2022;1–8.
  • Stuart KV, Shepherd DJ, Kruger M, Singh E. The Incidence of Retinoblastoma in South Africa: findings from the South African National Cancer Registry (2004-2018). Ophthalmic Epidemiol. 2022;29(6):681–687. doi:10.1080/09286586.2021.2013900
  • Darwich R, Ghazawi FM, Rahme E, et al. Retinoblastoma Incidence Trends in Canada: a National Comprehensive Population-Based Study. J Pediatr Ophthalmol Strabismus. 2019;56(2):124–130. doi:10.3928/01913913-20190128-02
  • Chen YH, Lin HY, Hsu WM, Lee SM, Cheng CY. Retinoblastoma in Taiwan: incidence and survival characteristics from 1979 to 2003. Eye. 2010;24(2):318–322. doi:10.1038/eye.2009.80
  • Chiang C-J, You S-L, Chen C-J, Yang Y-W, W-C L, Lai M-S. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Japanese J Clin Oncol. 2015;45(3):291–296.
  • Chiang C-J, Wang Y-W, Lee W-C. Taiwan’s Nationwide Cancer Registry System of 40 years: past, present, and future. J Formos Med Assoc. 2019;118(5):856–858. doi:10.1016/j.jfma.2019.01.012
  • Cheng C-Y, Chiang C-J, Hsieh C-H, Chang Y-K, Lai M-S. Is quality of registry treatment data related to registrar experience and workload? A study of Taiwan cancer registry data. JFormos Med Assoc. 2018;117(12):1093–1100. doi:10.1016/j.jfma.2017.12.012
  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
  • Vega-Escobar K, Bonilla-Escobar FJ, Salamanca O, et al. Epidemiology of Eye Cancer in Cali, Colombia: a 55-Year Study. Ophthalmic Epidemiol;2023. 1–11. doi:10.1080/09286586.2023.2269253
  • Wong JR, Tucker MA, Kleinerman RA, Devesa SS. Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program. JAMA Ophthalmol. 2014;132(4):478–483. doi:10.1001/jamaophthalmol.2013.8001
  • MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009;93(1):38–39. doi:10.1136/bjo.2008.139626
  • Chu CC, Xie Y, R-r Y. Effects of sibship structure revisited: evidence from intrafamily resource transfer in Taiwan. Sociol Educ. 2007;80(2):91–113. doi:10.1177/003804070708000201
  • Li SY, Chen SC, Tsai CF, Sheu SM, Yeh JJ, Tsai CB. Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011. Br J Ophthalmol. 2016;100(6):839–842. doi:10.1136/bjophthalmol-2015-307211
  • Chen P-Y, Kao L-Y, Chao A-N, et al. Retinoblastoma in Taiwan: survival and clinical characteristics. Japanese J Ophthalmol. 2021;65(4):546–553. doi:10.1007/s10384-021-00836-6
  • Tomar AS, Finger PT, Gallie B, et al. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: part II: treatment Success and Globe Salvage. Ophthalmology. 2020;127(12):1733–1746. doi:10.1016/j.ophtha.2020.05.051
  • Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005;18(1):41–53, viii. doi:10.1016/j.ohc.2004.11.003
  • Scelfo C, Francis JH, Khetan V, et al. An international survey of classification and treatment choices for group D retinoblastoma. Int j Ophthalmol. 2017;10(6):961–967. doi:10.18240/ijo.2017.06.20
  • Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68(11):2356–2365. doi:10.4103/ijo.IJO_721_20